Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Influenza, Human × influvac × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1 Influenza, Human 1

Interventions

Influenza Vaccines 16 trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine 2 Vaccines 2 Oseltamivir 2 FluMist 2 Cyclophosphamide 2 ziprasidone 1 vaxigrip 1 thymoglobulin 1 peginterferon alfa-2a 1 influvac 1 fludarabine 1 baloxavir 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Starch 1 Spironolactone 1 Sevelamer 1 SARS-CoV-2 inactivated vaccines 1 Rocuronium 1 Rituximab 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nivolumab 1 Nifedipine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01707628 2014-01-31

Rituxivac

St. Antonius Hospital

Phase NA Completed

Influenza, Human, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡